Key facts
- Saiying Capital is a other based in Beijing, China with 6 tracked portfolio companies.
- Notable positions include GeneCradle, Arthrone, Cyberpai (Wuxi) Technology, Inhal Pharma, Inno Medicine.
About Saiying Capital
Saiying Capital is a direct investment firm based in Beijing, China. Established in 2016, the firm was established by Saisheng Pharmaceutical (SZ: 300485) in cooperation with E-town International Investment and E-town Biomedical Park. The core of its investment strategy is made up of M&A and direct investment. The firm seeks to make investments in the healthcare sector. The assets are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for Saiying Capital's activity
Create free account
No card required
Portfolio, priced
6 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| GeneCradle | — | $287.8M | — | |
| Arthrone | — | $111.0M | — | |
| Cyberpai (Wuxi) Technology | — | — | — | |
| Inhal Pharma | — | — | — | |
| Inno Medicine | — | — | — | |
| Vbiosci | — | — | — |
Frequently asked
- What companies does Saiying Capital invest in?
- Saiying Capital has 6 recorded portfolio companies, including GeneCradle, Arthrone, Cyberpai (Wuxi) Technology, Inhal Pharma.